• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘内注射巴氯芬治疗前患者的期望:一项具有 1 年随访的纵向研究。

Patients' Expectations Before Initiation of Intrathecal Baclofen Treatment: A Longitudinal Study with 1-Year Follow-Up.

机构信息

Department of Rehabilitation Medicine and Department of Health, Medicine and Caring Sciences, Linköping University.

Pain and Rehabilitation Centre and Department of Health, Medicine and Caring Sciences, Linköping University.

出版信息

J Rehabil Med. 2023 Jan 31;55:jrm00371. doi: 10.2340/jrm.v55.3424.

DOI:10.2340/jrm.v55.3424
PMID:36718657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9904143/
Abstract

OBJECTIVE

To investigate patients' expectations, met/unmet expectations and satisfaction with intrathecal baclofen treatment in relation to effect on spasticity, pain intensity, sleep quality, occupational performance, well-being and self-efficacy.

DESIGN

A prospective longitudinal study with follow-up at 1 year.

PATIENTS

Consecutive patients, age ≥ 18 years with a disabling spasticity of cerebral or spinal origin selected for intrathecal baclofen treatment at 2 university hospitals in Sweden were included. From August 2016 to June 2019, 35 patients began intrathecal baclofen treatment; 29 patients were included and completed the study.

METHODS

Baseline and 1-year follow-up included assessment of spasticity by physiotherapists, a semi-structured interview regarding occupational performance using the Canadian Occupational Performance Measure and a questionnaire.

RESULTS

Overall satisfaction with treatment and satisfaction with occupational performance were reported as moderate. Important variables that explained satisfaction with occupational performance were improvements in performance, expectations and performance before treatment. Patients had higher expectations compared with the 1-year outcomes regarding occupational performance, spasticity, pain intensity and sleep quality, although improvements were reported.

CONCLUSION

A thorough discussion of goal setting with intrathecal baclofen treatment before implantation is necessary to give patients individual and realistic expectations.

摘要

目的

调查与鞘内巴氯芬治疗的效果(对痉挛、疼痛强度、睡眠质量、职业表现、幸福感和自我效能的影响)相关的患者期望、期望满足情况和满意度。

设计

前瞻性纵向研究,随访时间为 1 年。

患者

连续选择在瑞典 2 所大学医院接受鞘内巴氯芬治疗的、年龄≥18 岁、有因脑或脊髓起源导致的致残性痉挛的患者。2016 年 8 月至 2019 年 6 月,35 例患者开始接受鞘内巴氯芬治疗;29 例患者入组并完成了研究。

方法

基线和 1 年随访时,理疗师评估痉挛情况,采用加拿大职业表现量表进行半结构化访谈评估职业表现,并采用问卷评估。

结果

治疗总体满意度和职业表现满意度报告为中等。能够解释职业表现满意度的重要变量是治疗前后的表现改善、期望和表现。尽管患者报告了改善,但与 1 年结果相比,他们对职业表现、痉挛、疼痛强度和睡眠质量的期望更高。

结论

在植入前需要对鞘内巴氯芬治疗进行目标设定的充分讨论,以给患者提供个性化和现实的期望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba7/9904143/c56c07a67265/JRM-55-3424-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba7/9904143/f8a7a27a263b/JRM-55-3424-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba7/9904143/c56c07a67265/JRM-55-3424-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba7/9904143/f8a7a27a263b/JRM-55-3424-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ba7/9904143/c56c07a67265/JRM-55-3424-g002.jpg

相似文献

1
Patients' Expectations Before Initiation of Intrathecal Baclofen Treatment: A Longitudinal Study with 1-Year Follow-Up.鞘内注射巴氯芬治疗前患者的期望:一项具有 1 年随访的纵向研究。
J Rehabil Med. 2023 Jan 31;55:jrm00371. doi: 10.2340/jrm.v55.3424.
2
Experiences from intrathecal baclofen treatment based on medical records and patient- and proxy-reported outcome: a multicentre study.基于病历和患者及代理人报告结局的鞘内巴氯芬治疗经验:一项多中心研究。
Disabil Rehabil. 2019 May;41(9):1037-1043. doi: 10.1080/09638288.2017.1419291. Epub 2018 Jan 8.
3
A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.使用可编程泵鞘内注射巴氯芬治疗顽固性痉挛的临床研究。
Arch Phys Med Rehabil. 2005 Nov;86(11):2165-71. doi: 10.1016/j.apmr.2005.05.018.
4
Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up.鞘内注射巴氯芬治疗多发性硬化相关痉挛:长期随访。
J Rehabil Med. 2011 May;43(6):511-4. doi: 10.2340/16501977-0811.
5
Long-term therapy with intrathecal baclofen improves quality of life in children with severe spastic cerebral palsy.鞘内注射巴氯芬长期治疗可改善重度痉挛型脑瘫患儿的生活质量。
Eur J Paediatr Neurol. 2017 May;21(3):565-569. doi: 10.1016/j.ejpn.2017.01.016. Epub 2017 Feb 11.
6
Effects of severe spasticity treatment with intrathecal Baclofen in multiple sclerosis patients: Long term follow-up.鞘内注射巴氯芬治疗多发性硬化症患者严重痉挛的效果:长期随访
NeuroRehabilitation. 2016 Apr 6;38(4):385-93. doi: 10.3233/NRE-161329.
7
Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system.使用鞘内持续巴氯芬输注系统治疗重度脊髓痉挛的成本分析。
Pharmacoeconomics. 1999 Apr;15(4):395-404. doi: 10.2165/00019053-199915040-00007.
8
Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study.鞘内注射巴氯芬治疗顽固性脑性痉挛:一项前瞻性安慰剂对照双盲研究。
Neurosurgery. 2000 Mar;46(3):603-9; discussion 609-12. doi: 10.1097/00006123-200003000-00017.
9
Intrathecal Baclofen Infusion Pumps in the Treatment of Spasticity: A Retrospective Cohort Study in a Portuguese Centre.鞘内注射巴氯芬泵治疗痉挛:葡萄牙某中心的一项回顾性队列研究
Acta Med Port. 2019 Dec 2;32(12):754-759. doi: 10.20344/amp.10482.
10
The effect of intrathecal baclofen on muscle co-contraction in children with spasticity of cerebral origin.鞘内注射巴氯芬对脑源性痉挛儿童肌肉协同收缩的影响。
Pediatr Neurosurg. 2002 Nov;37(5):225-30. doi: 10.1159/000066212.

本文引用的文献

1
European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and/or botulinum toxin type A.欧洲专家共识:改善鞘内注射巴氯芬和/或肉毒毒素 A 治疗致残性痉挛患者选择的方法。
J Rehabil Med. 2022 Jan 3;54:jrm00241. doi: 10.2340/16501977-2877.
2
Characterizing the Experience of Spasticity after Spinal Cord Injury: A National Survey Project of the Spinal Cord Injury Model Systems Centers.描述脊髓损伤后痉挛的体验:脊髓损伤模型系统中心的全国性调查项目。
Arch Phys Med Rehabil. 2022 Apr;103(4):764-772.e2. doi: 10.1016/j.apmr.2021.03.040. Epub 2021 May 17.
3
Dosing Patterns In Treatment of Disabling Spasticity With Intrathecal Baclofen.
鞘内注射巴氯芬治疗致残性痉挛的剂量模式。
Rehabil Nurs. 2021;46(6):315-322. doi: 10.1097/RNJ.0000000000000323.
4
Understanding Patient Expectations of Health Care: A Qualitative Study.了解患者对医疗保健的期望:一项定性研究。
J Patient Exp. 2020 Dec;7(6):1724-1731. doi: 10.1177/2374373520921692. Epub 2020 Apr 28.
5
Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience.鞘内注射巴氯芬治疗多发性硬化相关痉挛:二十年经验。
Mult Scler Relat Disord. 2019 Jan;27:95-100. doi: 10.1016/j.msard.2018.10.009. Epub 2018 Oct 15.
6
User's guide to correlation coefficients.相关系数用户指南。
Turk J Emerg Med. 2018 Aug 7;18(3):91-93. doi: 10.1016/j.tjem.2018.08.001. eCollection 2018 Sep.
7
Experiences from intrathecal baclofen treatment based on medical records and patient- and proxy-reported outcome: a multicentre study.基于病历和患者及代理人报告结局的鞘内巴氯芬治疗经验:一项多中心研究。
Disabil Rehabil. 2019 May;41(9):1037-1043. doi: 10.1080/09638288.2017.1419291. Epub 2018 Jan 8.
8
Inter- and intra-rater reliability of the Modified Ashworth Scale: a systematic review and meta-analysis.改良 Ashworth 量表的组内和组间可靠性:系统评价和荟萃分析。
Eur J Phys Rehabil Med. 2018 Aug;54(4):576-590. doi: 10.23736/S1973-9087.17.04796-7. Epub 2017 Sep 13.
9
Best Practices for Intrathecal Baclofen Therapy: Patient Selection.鞘内注射巴氯芬治疗的最佳实践:患者选择
Neuromodulation. 2016 Aug;19(6):607-15. doi: 10.1111/ner.12447. Epub 2016 Jul 19.
10
Best Practices for Intrathecal Baclofen Therapy: Screening Test.鞘内注射巴氯芬治疗的最佳实践:筛查测试。
Neuromodulation. 2016 Aug;19(6):616-22. doi: 10.1111/ner.12437. Epub 2016 Jul 19.